0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Diseases Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Recurrent Herpes Labialis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Recurrent Herpes Labialis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Hepatitis B Virus (HBV) Infection - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis B Virus (HBV) Infection - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
hepatits B virus Infection - Epidemiology Forecast to 2032 - Product Thumbnail Image

hepatits B virus Infection - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Herpes Genitalis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Herpes Genitalis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Lyme disease (LD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Lyme disease (LD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Hepatitis D - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis D - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Candidemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Candidemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Nontuberculous Mycobacterial (NTM) Infections - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nontuberculous Mycobacterial (NTM) Infections - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Aspergillosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Aspergillosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021 - Product Thumbnail Image

Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - Product Thumbnail Image

HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

  • Report
  • December 2023
  • 109 Pages
  • Global
From
EUR$4,000USDGBP
South & Central America Infectious Disease Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Class, Indication, Route Of Administration and Distribution Channel - Product Thumbnail Image

South & Central America Infectious Disease Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Class, Indication, Route Of Administration and Distribution Channel

  • Report
  • July 2024
  • 90 Pages
From
EUR$3,450USDGBP
North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • May 2024
  • 84 Pages
  • North America
From
EUR$3,450USDGBP
Middle East & Africa Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

Middle East & Africa Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • May 2024
  • 120 Pages
  • Africa, Middle East
From
EUR$3,450USDGBP
Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • May 2024
  • 87 Pages
  • Europe
From
EUR$3,450USDGBP
Asia Pacific Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

Asia Pacific Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • May 2024
  • 88 Pages
  • Asia Pacific
From
EUR$3,450USDGBP
South & Central America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel - Product Thumbnail Image

South & Central America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

  • Report
  • May 2024
  • 75 Pages
From
EUR$3,450USDGBP
MEA Respiratory Tract Infection Treatment Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country - Product Thumbnail Image

MEA Respiratory Tract Infection Treatment Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug, Disease Indication, Route of Administration, Age Group, Distribution Channel, and Country

  • Report
  • March 2024
  • 201 Pages
  • Africa, Middle East
From
EUR$3,450USDGBP
Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel - Product Thumbnail Image

Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel

  • Report
  • January 2024
  • 193 Pages
  • Global
From
EUR$4,450USDGBP
Hospital Acquired Infection Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Class, Infection Type, Distribution Channel, and Geography - Product Thumbnail Image

Hospital Acquired Infection Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Class, Infection Type, Distribution Channel, and Geography

  • Report
  • December 2023
  • 171 Pages
  • Global
From
EUR$4,450USDGBP
Loading Indicator

The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market. Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans. Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more